Week 486 Review - Great week despite some disappointment as Optibiotix flies.

The deficit between cost and value narrowed by an impressive £8,855 to £117,998, mainly thanks to a big rise on OPTI:Optibiotix. The deficit between injection amount and value dropped to £48,331 and total portfolio value increased to £115,281.

Worst performer was PBX:Probiotix Health which looked like a corner had been turned, but most of the gains have been lost. They dropped 17% and are back at 5p so not much higher than the all-time low.

CORE:Solidcore Resources may have been sliding for a few weeks, but I couldn't access their share price from Madagascar, so am catching up this week with a 13% drop since I last recorded them.

PAF:Pan African Resources fell 10% as the gold price is hit again.

JLP:Jubilee Metals looked like the seller had gone, but they haven't. I reckon they just waited a few weeks for the share price to get above their 5p cut-off and are now at it again, with an 8% loss this week.

CMCL:Caledonia Mining continue to under-perform and dropped another 6% to go 17% down.

ARBB:Arbuthnot Banking have had a bad few weeks, but went up 5% this week and are now only 14% down.

PAGE:Pagegroup climbed 5% but are still down by 28%.

SAE:Simec Atlantis Energy recovered 6% but are 78% down.

AAL:Anglo American Mining have been flogging stuff off. They are up 7% and my holding has just about nudged into profit.

AFC:AFC Energy continue to by very volatile and went up 13%, but are still 41% down.

Share of the week is OPTI:Optibiotix, which went up 26% and accounted for much of the week's gains. That was with no news - we can only hope it does the same if there is any news. Unfortunately it's often the opposite.

Here's the ISA and shares portfolio after week 18 of year 10.

			Weekly Change
Cash	£98.60		+£95.45
Portfolio cost	£111,553.84		+£0
Portfolio sell value (bid price-commission)	£47,630.80	(-57.3%)	+£4,362.07
Potential profits	£0		+£0
Yr 10 Dividends	£53.50		+£0
Yr 10 Interest	£0.40		+£0
Yr 10 Profit from sales	£243.66		+£0
Yr 10 proj avg monthly profit	£63.59	(0.9%)	-£4.91
Total Dividends	£12,275.99		+£0
Total Interest	£7.20		+£0
Total Profit from sales	£18,121.50		+£0
Average monthly cash profit	£266.63	(3.9%)	-£0.59
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	36%		+0%

I added £100 to my ISA to make sure I have enough to cover fees. Not much else happened aside from the big surge in value. Still nothing in profit.

Nice.

We've crossed the trend line!

The SIPP looks like this after week 469 overall and week 1 of year 10.

			Weekly Change
Cash	£268.95		+£156.60
Portfolio cost	£119,221.31		+£0
Portfolio sell value (bid price - commission)	£66,018.47	(-44.6%)	+£4,557.32
Potential profits	£5,590.57		-£725.76
Yr 9 Dividends	£34.30		+£34.30
Yr 9 Interest	£0		+£0
Yr 9 Profit from sales	£0		+£0
Yr 9 proj avg monthly profit	£68.40	(1.0%)	+£68.40
Total Dividends	£16,150.95		+£34.30
Total Interest	£12.90		+£0
Total Profit from sales	£17,007.94		+£0
Average monthly cash profit	£293.08	(4.5%)	-£0.33
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	40%		+0%

Cash came from a tax rebate, a £9 dividend from GAW:Games Workshop, and a £24 dividend from UKW:Greencoat UK Wind. Potential profits down due to gold slipping, but portfolio value well up.

Promising.

Also above the trend line.

The trading account looks like this after week 435 overall and week 19 of year 9.

			Weekly Change
Cash	£63.39		+£0
Portfolio cost	£2,073.87		+£0
Portfolio sell value (bid price - commission)	£1,201.49	(-42.1%)	-£63.80
Potential profits	£0		+£0
Year 9 Dividends	£0		+£0
Year 9 Interest	£0		+£0
Year 9 Profit	£0		+£0
Yr 8 proj avg monthly profit	£0	(+0%)	+£0
Dividends	£85.46		+£0
Interest	£0.03		+£0
Profit from sales	-£602.54		+£0
Average monthly cash profit	-£5.14	(-3.0%)	+£0.01
(Sold stocks profit + Dividends - Fees / Months)

The big drop in JLP:Jubilee Metals caused a drop in value of £63.

It was looking better a few weeks ago

Drat! Just as the other accounts cross the trend line, this take a nosedive.

That's the holiday backlog cleared up. Wonder if we'll get a Santa rally this year? There's been absolutely no evidence of one in my portfolio for the last 10 years so I won't hold my breath.

Week 485 Review - Another fairly flat week.

The deficit between cost and value widened by just £489 to £126,853, and deficit to injection amount rose to £57,339. The total portfolio value is £106,174.

CWR:Ceres Power goes from bad to worse, losing another 8% and suggesting they won't stay in the FTSE 250 for very long.

TRX:Tissue Regenix dropped 8% presumably because nothing seems to be forthcoming on whether they are selling the company.

FXPO:Ferrexpo lost 5% as they continue to yo-yo.

III:3i Group just keeps delivering, with another 5% growth this week taking them to 121% up.

SAE:Simec Atlantis Energy rose 5% for no clear reason.

GAW:Games Workshop rose a whopping 15% to go 46% up.

SBTX:SkinBioTherapeutics reversed last week's decline and went up 19%.

Share of the Week is PAF:Pan African Resources which rebounded from a 10% loss last week to go up by 21% and my cheapest holding is now £122% up.

Here's the ISA and shares portfolio after week 17 of year 10.

			Weekly Change
Cash	£3.15		+£0
Portfolio cost	£111,553.84		+£0
Portfolio sell value (bid price-commission)	£43,268.73	(-61.2%)	-£884.24
Potential profits	£0		+£0
Yr 10 Dividends	£53.50		+£0
Yr 10 Interest	£0.40		+£0
Yr 10 Profit from sales	£243.66		+£0
Yr 10 proj avg monthly profit	£68.50	(1.0%)	-£4.28
Total Dividends	£12,275.99		+£0
Total Interest	£7.20		+£0
Total Profit from sales	£18,121.50		+£0
Average monthly cash profit	£267.22	(3.9%)	-£0.55
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	36%		+0%

Quite a big drop in value and no gold to off-set.

Slowly wiping out the gains from a few weeks ago,

Determined not to cross the trend line

The SIPP looks like this after week 469 overall and week 1 of year 10.

			Weekly Change
Cash	£112.35		+£0
Portfolio cost	£119,221.31		+£0
Portfolio sell value (bid price - commission)	£61,461.15	(-48.4%)	+£360.66
Potential profits	£6,316.33		+£1,441.99
Yr 9 Dividends	£0		+£0
Yr 9 Interest	£0		+£0
Yr 9 Profit from sales	£0		+£0
Yr 9 proj avg monthly profit	£0	(0.0%)	+£0
Total Dividends	£16,116.65		+£0
Total Interest	£12.90		+£0
Total Profit from sales	£17,007.94		+£0
Average monthly cash profit	£293.41	(4.5%)	-£0.63
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	40%		+0%

Much better performance here, with potential profits up by £1,441 and portfolio value also up.

Boring

Determined to stay under the trend line

The trading account looks like this after week 435 overall and week 19 of year 9.

			Weekly Change
Cash	£63.39		+£0
Portfolio cost	£2,073.87		+£0
Portfolio sell value (bid price - commission)	£1,265.29	(-39.0%)	+£34.13
Potential profits	£0		+£0
Year 9 Dividends	£0		+£0
Year 9 Interest	£0		+£0
Year 9 Profit	£0		+£0
Yr 8 proj avg monthly profit	£0	(+0%)	+£0
Dividends	£85.46		+£0
Interest	£0.03		+£0
Profit from sales	-£602.54		+£0
Average monthly cash profit	-£5.15	(-3.0%)	+£0.01
(Sold stocks profit + Dividends - Fees / Months)

Pretty good thanks to SBTX:SkinBioTherapeutics.

Back to heading upwards

Touching the trend line!

Week 484 Review - Although it appears flat, there were lots of big losers this week.

The deficit between cost and value only widened by £153, which is as flat as it gets. It now stands at £126,364, and the deficit between injection amount and value widened to £56,599. Total value increased to £106,663 thanks to injection of cash for monthly savings.

CMCL:Caledonia Mining plunged 22% after insipid Q3 results. There weren't great, but I don't understand how a quarter of the share price can be lost. I've always done badly with this company, and it's looking like this time will be the same.

PAF:Pan African Resources dropped 10% so it looks like all gold miners had a bad week.

FOUR:4imprint dropped 7% which wiped out most of last week's gains and sent them to loss.

SBTX:SkinBioTherapeutics fell again, this time by 7%.

ARBB:Arbuthnot Banking dropped 6% for no reason, and are now 18% down.

ATYM:Atalaya Mining fell 6% to go 22% down.

GSK:GSK have been a disaster and dropped another 6% to go 21% down.

AFC:AFC Energy fell another 5% and are 48% down.

CAML:Central Asia Metals fell another 5% after I bought a load, and are around half the value I think they should be.

UKW:Greencoat UK Wind dropped another 5% to go 19% down.

OPTI:Optibiotix has another good week, climbing 6% and helping reduce all the losses above.

FXPO:Ferrexpo went up another 7% but are still 83% down.

Share of the Week is TLOU:Tlou Energy, which went up 15%. I'm still 45% down but confident in getting that back when the substation is finished.

Here's the ISA and shares portfolio after week 16 of year 10.

			Weekly Change
Cash	£3.15		-£3.75
Portfolio cost	£111,553.84		+£0
Portfolio sell value (bid price-commission)	£44,152.97	(-60.4%)	+£552.23
Potential profits	£0		+£0
Yr 10 Dividends	£53.50		+£0
Yr 10 Interest	£0.40		+£0.03
Yr 10 Profit from sales	£243.66		+£0
Yr 10 proj avg monthly profit	£72.78	(1.1%)	-£5.92
Total Dividends	£12,275.99		+£0
Total Interest	£7.20		+£0.03
Total Profit from sales	£18,121.50		+£0
Average monthly cash profit	£267.77	(3.9%)	-£1.15
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	36%		+0%

Portfolio value went up by £552 in this account, as most of the big losers are in my SIPP this week.

Flat

Still not reaching the trend line

The SIPP looks like this after week 468 overall and week 52 of year 9.

			Weekly Change
Cash	£112.35		+£22.37
Portfolio cost	£119,221.31		+£227.62
Portfolio sell value (bid price - commission)	£61,100.49	(-48.8%)	-£685.65
Potential profits	£4,874.34		-£676.86
Yr 9 Dividends	£1,481.77		+£0
Yr 9 Interest	£6.97		+£0.52
Yr 9 Profit from sales	£6,172.04		+£0
Yr 9 proj avg monthly profit	£619.75	(9.4%)	-£13.52
Total Dividends	£16,116.65		+£0
Total Interest	£12.90		+£0.52
Total Profit from sales	£17,007.94		+£0
Average monthly cash profit	£294.04	(4.5%)	-£0.78
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	40%		+0%

This was hit hard by the drops in gold, and both potential profits and portfolio value dropped by around £680. The monthly injection was added and used to buy 4 shares in FOUR:4imprint at 5624.916p costing £227.63. Next month will be the last one I invest in FOUR.

This was the last week of year 9, and I'm very happy with the 9.4% performance from sales and dividends. That's pretty much my best ever year and suggests the magic formula plan is working.

Slight dip

Still below trend line

The trading account looks like this after week 434 overall and week 18 of year 9.

			Weekly Change
Cash	£63.39		+£0
Portfolio cost	£2,073.87		+£0
Portfolio sell value (bid price - commission)	£1,231.16	(-40.6%)	-£20.03
Potential profits	£0		+£0
Year 9 Dividends	£0		+£0
Year 9 Interest	£0		+£0
Year 9 Profit	£0		+£0
Yr 8 proj avg monthly profit	£0	(+0%)	+£0
Dividends	£85.46		+£0
Interest	£0.03		+£0
Profit from sales	-£602.54		+£0
Average monthly cash profit	-£5.16	(-3.0%)	+£0.01
(Sold stocks profit + Dividends - Fees / Months)

Slight drop. No drama.

The rise stops.

So close to the trend line.

Two holiday weeks caught up, just two more to go.

Week 483 Review - A good week takes us back over £100k.

A recovery for both OPTI:Optibiotix and JLP:Jubilee Metals saw the deficit between cost and value reduce by £7,178 to £126,210, and deficit between injection amount and value reduced to £56,692. Total portfolio value went back above £100k to £106,570.

ASHM:Ashmore Group had a dreadful week, losing 17%, so they are now 36% down.

CWR:Ceres Power also did really badly, dropping 14% to go 22% down after only recently being in profit.

SBTX:SkinBioTherapeutics have been pretty volatile and dropped 12% this week.

PSN:Persimmon dropped 10% to go from break-even to a 10% loss.

PBX:Probiotix Health fell 8% as the good news in recent results has now been forgotten.

CAML:Central Asia Metals inexplicably dropped 6% and despite being a massively profitable copper company are losing me lots of money.

SAE:Simec Atlantis Energy fell 6% and are now 80% down.

III:3i Group fought back against the shorters and gained 5% to go 108% up. A cynic would say the so-called shorting attack was just a ruse to try and get some cheaper shares.

FOUR:4imprint went up 8% and are now 3% in profit.

FXPO:Ferrexpo climbed 17% as people mistakenly think Trump can end the war. They are still 84% down and I don't have much hope in ever breaking even on them.

JLP:Jubilee Metals may have finally finished being sold by the big fund that's closing, as they went up 17% after a protracted and relentless fall. Some of my holdings are even in profit.

AFC:AFC Energy went up 20% for no obvious reason, but are still 45% down

Share of the Week is OPTI:Optibiotix, which went up 23% but I don't know why.

Here's the ISA and shares portfolio after week 15 of year 10.

			Weekly Change
Cash	£6.90		+£0
Portfolio cost	£111,553.84		+£0
Portfolio sell value (bid price-commission)	£43,600.74	(-60.9%)	+£4,095.73
Potential profits	£0		+£0
Yr 10 Dividends	£53.50		+£0
Yr 10 Interest	£0.37		+£0
Yr 10 Profit from sales	£243.66		+£0
Yr 10 proj avg monthly profit	£78.70	(1.2%)	-£5.62
Total Dividends	£12,275.99		+£0
Total Interest	£7.17		+£0
Total Profit from sales	£18,121.50		+£0
Average monthly cash profit	£268.36	(3.9%)	-£0.56
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	36%		+0%

Big increase thanks to OPTI:Optibiotix and JLP:Jubileee Metals.

Tiny tick up

Still below the trend line

The SIPP looks like this after week 467 overall and week 51 of year 9.

			Weekly Change
Cash	£89.98		-£170.42
Portfolio cost	£118,993.69		+£750.31
Portfolio sell value (bid price - commission)	£61,558.52	(-48.3%)	+£3,003.40
Potential profits	£5,551.20		+£445.25
Yr 9 Dividends	£1,481.77		+£14.00
Yr 9 Interest	£6.45		+£0
Yr 9 Profit from sales	£6,172.04		+£565.89
Yr 9 proj avg monthly profit	£633.27	(9.7%)	+£37.59
Total Dividends	£16,116.65		+£14.00
Total Interest	£12.38		+£0
Total Profit from sales	£17,007.94		+£565.89
Average monthly cash profit	£294.82	(4.5%)	+£4.76
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	40%		+0%

Just as I was about to go on holiday I decided to sell the JLP:Jubilee Metals shares I had bought after selling most of my CAML:Central Asia Metals holding. I sold 82,361 shares for 5.2401p making £565.89 (15%) profit. I bought back 2,640 CAML:Central Asia Metals shares for 169.5576p costing £4,488.27. That's 580 more than I originally sold, so I've increased my holding by 28% as a result of lending the cash to JLP. That doesn't usually work for me, so it makes a nice change.

I got a £14 dividend from PSN:Persimmon, and potential profits rose by £445 despite cashing in £565 from the sale.

Still a disappointingly small tick up.

So nearly crossing the trend line.

The trading account looks like this after week 433 overall and week 17 of year 9.

			Weekly Change
Cash	£63.39		+£0
Portfolio cost	£2,073.87		+£0
Portfolio sell value (bid price - commission)	£1,251.19	(-39.7%)	+£79.56
Potential profits	£0		-£31.81
Year 9 Dividends	£0		+£0
Year 9 Interest	£0		+£0
Year 9 Profit	£0		+£0
Yr 8 proj avg monthly profit	£0	(+0%)	+£0
Dividends	£85.46		+£0
Interest	£0.03		+£0
Profit from sales	-£602.54		+£0
Average monthly cash profit	-£5.17	(-3.0%)	+£0.02
(Sold stocks profit + Dividends - Fees / Months)

The rise in JLP:Jubilee Metals caused value to go up by £79, but the crash in SBTX:SkinBioTherapeutics wiped out all potential profits.

A more encouraging slope upwards.

Another one eager to cross the trend line.

That's it for Week 483. Lots of holiday entries to catch up on, as I was able to take weekly snapshots so can write them all up now I'm back.